So PR is indicating that JV partners are pretty much locked in and are waiting on Phase III approval.
Approximately AUD$90mill required for Phase III trial
No indication yet that he is looking to put a new chairman of the board in place
FDA approval late 2026/2027 barring delays
TGA approval possibly late 2025.
research reports and media, page-4293
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.8¢ |
Change
0.003(0.85%) |
Mkt cap ! $103.1M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 29.5¢ | $34.53K | 115.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 40539 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 56 | 1 |
View Market Depth
| Last trade - 15.59pm 22/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |